Loading...
Future of targeted agents in metastatic colorectal cancer
Great strides have been made in improving the outcome of patients with metastatic colorectal cancer and targeted agents are an important part of the treatment arsenal. The approved monoclonal antibodies, bevacizumab, cetuximab and panitumumab, are part of the standard of care, yet only recently have...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3834580/ https://ncbi.nlm.nih.gov/pubmed/24273599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/crc.12.52 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|